Antibiotic: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Robert Badgett
(Organized adverse effects and started diarrhea)
imported>Robert Badgett
(→‎Antibiotic resistance: Moved content to antibiotic resistance article)
Line 218: Line 218:
{{main|antibiotic resistance}}
{{main|antibiotic resistance}}
A number of organisms have developed resistance to antibiotics. At the microbial level, this may be due either to the antibiotic therapy allowing the survival of naturally resistant organisms of the species, or of the transfer of resistance genetic factors among bacteria.
A number of organisms have developed resistance to antibiotics. At the microbial level, this may be due either to the antibiotic therapy allowing the survival of naturally resistant organisms of the species, or of the transfer of resistance genetic factors among bacteria.
Assorted human actions cause much of the development of resistance, with reasons ranging to overprescribing antibiotics in situations where they are unlikely to help<ref name="pmid18665065">{{cite journal |author=Ranji SR, Steinman MA, Shojania KG, Gonzales R |title=Interventions to reduce unnecessary antibiotic prescribing: a systematic review and quantitative analysis |journal=Med Care |volume=46 |issue=8 |pages=847–62 |year=2008 |month=August |pmid=18665065 |doi=10.1097/MLR.0b013e318178eabd |url=http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00005650-200808000-00012 |issn=}}</ref>, to patients stopping therapy when they feel better but still have an active bacterial infection, to the use of antibiotics as agricultural growth stimulants.
Regarding overprescribing, one study on [[respiratory tract infection]]s found "physicians were more likely to prescribe antibiotics to patients who they believed expected them, although they (the physicians) correctly identified only about 1 in 4 of those patients".<ref name="pmid17467120">{{cite journal |author=Ong S, Nakase J, Moran GJ, Karras DJ, Kuehnert MJ, Talan DA |title=Antibiotic use for emergency department patients with upper respiratory infections: prescribing practices, patient expectations, and patient satisfaction |journal=Annals of emergency medicine |volume=50 |issue=3 |pages=213-20 |year=2007 |pmid=17467120 |doi=10.1016/j.annemergmed.2007.03.026}}</ref> The use of antibiotics varies among countries.<ref name="pmid19549995">{{cite journal |author=Butler CC, Hood K, Verheij T, ''et al.'' |title=Variation in antibiotic prescribing and its impact on recovery in patients with acute cough in primary care: prospective study in 13 countries |journal=BMJ |volume=338 |issue= |pages=b2242 |year=2009 |pmid=19549995 |doi= |url=http://bmj.com/cgi/pmidlookup?view=long&pmid=19549995 |issn=}}</ref> Multifactorial interventions aimed at both physicians and patients can reduce inappropriate prescribing of antibiotics. <ref name="pmid17509729">{{cite journal |author=Metlay JP, Camargo CA, MacKenzie T, ''et al'' |title=Cluster-randomized trial to improve antibiotic use for adults with acute respiratory infections treated in emergency departments |journal=Annals of emergency medicine |volume=50 |issue=3 |pages=221-30 |year=2007 |pmid=17509729 |doi=10.1016/j.annemergmed.2007.03.022}}</ref> Delaying antibiotics for 48 hours while waiting on improvement of [[respiratory tract infection]]s<ref name="pmid17636757">{{cite journal |author=Spurling G, Del Mar C, Dooley L, Foxlee R |title=Delayed antibiotics for respiratory infections |journal=Cochrane database of systematic reviews (Online) |volume= |issue=3 |pages=CD004417 |year=2007 |pmid=17636757 |doi=10.1002/14651858.CD004417.pub3}}</ref><ref name="pmid19843421">{{cite journal| author=Moore M, Little P, Rumsby K, Kelly J, Watson L, Warner G et al.| title=Effect of antibiotic prescribing strategies and an information leaflet on longer-term reconsultation for acute lower respiratory tract infection. | journal=Br J Gen Pract | year= 2009 | volume= 59 | issue= 567 | pages= 728-34 | pmid=19843421
| url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=clinical.uthscsa.edu/cite&email=badgett@uthscdsa.edu&retmode=ref&cmd=prlinks&id=19843421 | doi=10.3399/bjgp09X472601 | pmc=PMC2751917 }} <!--Formatted by http://sumsearch.uthscsa.edu/cite/--></ref> or [[cystitis]]<ref name="pmid19364448">{{cite journal |author=Little P, Turner S, Rumsby K, ''et al'' |title=Dipsticks and diagnostic algorithms in urinary tract infection: development and validation, randomised trial, economic analysis, observational cohort and qualitative study |journal=Health Technol Assess |volume=13 |issue=19 |pages=iii–iv, ix–xi, 1–73 |year=2009 |month=March |pmid=19364448 |doi=10.3310/hta13190 |url=http://www.hta.ac.uk/execsumm/summ1319.htm |issn=}}</ref> may reduce antibiotic usage; however, this strategy may reduce patient satisfaction.
Normal [[c-reactive protein]] levels have been used to help [[health care provider]]s reduce antibiotic use.<ref name="pmid19416992">{{cite journal |author=Cals JW, Butler CC, Hopstaken RM, Hood K, Dinant GJ |title=Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial |journal=BMJ |volume=338 |issue= |pages=b1374 |year=2009 |pmid=19416992 |pmc=2677640 |doi= |url=http://bmj.com/cgi/pmidlookup?view=long&pmid=19416992 |issn=}}</ref>
Normal [[procalcitonin]] levels have been used to help [[health care provider]]s reduce antibiotic use.<ref name="pmid16603606">{{cite journal |author=Christ-Crain M, Stolz D, Bingisser R, ''et al.'' |title=Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial |journal=Am. J. Respir. Crit. Care Med. |volume=174 |issue=1 |pages=84–93 |year=2006 |month=July |pmid=16603606 |doi=10.1164/rccm.200512-1922OC |url=http://ajrccm.atsjournals.org/cgi/pmidlookup?view=long&pmid=16603606 |issn=}}</ref><ref name="pmid17218551">{{cite journal |author=Stolz D, Christ-Crain M, Bingisser R, ''et al.'' |title=Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy |journal=Chest |volume=131 |issue=1 |pages=9–19 |year=2007 |month=January |pmid=17218551 |doi=10.1378/chest.06-1500 |url=http://www.chestjournal.org/cgi/pmidlookup?view=long&pmid=17218551 |issn=}}</ref><ref name="pmid14987884">{{cite journal |author=Christ-Crain M, Jaccard-Stolz D, Bingisser R, ''et al.'' |title=Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial |journal=Lancet |volume=363 |issue=9409 |pages=600–7 |year=2004 |month=February |pmid=14987884 |doi=10.1016/S0140-6736(04)15591-8 |url=http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(04)15591-8 |issn=}}</ref><ref name="pmid18852401">{{cite journal |author=Briel M, Schuetz P, Mueller B, ''et al'' |title=Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care |journal=Archives of internal medicine |volume=168 |issue=18 |pages=2000–7; discussion 2007–8 |year=2008 |month=October |pmid=18852401 |doi=10.1001/archinte.168.18.2000 |url=http://archinte.ama-assn.org/cgi/pmidlookup?view=long&pmid=18852401 |issn=}}</ref>


===Diarrhea===
===Diarrhea===

Revision as of 06:30, 19 May 2010

This article is developed but not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable, developed Main Article is subject to a disclaimer.

Antibiotics reduce the growth or reproduction of cells, usually bacterial, and are used as medications to treat infections and some cancers. They interfere with the life cycle of cells in a number of different ways. Some antibiotics, like penicillin, interfere with cell wall synthesis.

Antivirals may be reverse transcriptase inhibitors that interefere with the production of viral RNA and DNA. Other antibiotics are nucleoside analogs that get incorporated into the viral RNA or DNA and act a chain terminators.


Classes of antibiotics

Penicillins

Penicillins have a common beta-lactam base structure, as shown, where R represents different chemical groups. Penicillins work by binding to penicillin-binding proteins irreversibly in a ring-opening reaction and disrupting bacterial cell wall synthesis. Some bacteria are resistant to penicillin because they have acquired the ability to make penicillinases, enzymes which degrade penicillin.

(CC) Image: David E. Volk
The core structure of penicillin

Cephalosporins

(CC) Image: David E. Volk
Base structure of all cephalosporins.

Cephalosporins are a class of antibiotic compounds sharing a common beta-lactam base structure, 7-aminocephalosporanic acid (7-ACA), that was derived from the first cephalosporin discovered, cephalosporin C. Penicillins are very similar, although they contain a five-membered ring in place of the six-membered ring present in the cephalosporin. The activity of cephalosporins, penicillins, and some other antibiotics are due to the presence of a beta-lactam, which binds irreversibly, via acylation, to penicillin-binding proteins, thereby inhibiting the peptidogycan layer of bacterial cell wall synthesis. Cephalosporins are often made semisynthetically. Cephalosporins and the very closely relatedcephamycins are collectively referred to as cephems. In general, second generation and later cephalosporins have a broader spectrum of activity against Gram-negative bacteria.

Because the original cephalosporins used the "ceph" form of the spelling and were often trademarked, the International Nonproprietary Names (INN) suggested by the World Health Organization use the "cef" spelling for the generic drug name of all cephalosporins.

Miscellaneous beta-lactams

Several antibiotics contain the beta-lactam ring, but are not considered either penicillins or cephalosporins.

Tetracyclines

Tetracyclines are antibiotics having a common base structure consisting of four rings conjoined in a linear fashion, with differing chemical groups attached to it, typically on the bottom side or the amino group on the left side in the figure shown. Tetracyclines hinder translation by binding to the 30S ribosomal subunit and preventing the amino-acyl tRNA from binding to the A site of the ribosome, thus disrupting the synthesis of bacterial proteins.


(CC) Image: David E. Volk
Minocycline, a tetracycline drug.

Quinolones

The mechanism of action for quinolones is different from that of macrolides, beta-lactams, aminoglycosides, or tetracyclines, so organisisms resistant to those classes of antibiotic drugs may be susceptible to quinolones. In particular, the quinolones interfere with topoisomerase enzymes, including topoisomerase II (DNA gyrase) and topoisomerase IV, which are vital to bacterial DNA replication, transcription, repair and recombination. Because the use of fluoroquinolones may lead to tendinitis or tendon rupture, especially in the Achilles tendon, the FDA requires a "black box" warning for these medications. The cause of the tendon damage is not yet determined.

(CC) Image: David E. Volk
Ciprofloxacin, a simple fluoroquinolone

Aminoglycosides

All patients taking aminoglycoside antibiotics should be under close observation due to concerns of ototoxicity and nephrotoxicity. These antibiotics have low activity against Gram-positive bacteria and are often used in conjuntion with other antibiotics from a different antibiotic class. They function by inhibiting bacterial protein synthesis.

Macrolides and ketolides

Macrolide antibiotics function by binding to the 50S subunit of the bacterial 70S ribosome, thus interferring with the translocation of peptides and the production of bacterial proteins.

Sulfonamides

Sulfonamides, (R-SO2-NH2) are competitive inhibitors of para-aminobenzoic acid (PABA), the natural substrate for the enzymedihydropteroate synthetase, which is required within the folic acid cycle for the production of folic acid. The sulfonamides are bacteriostatic rather than bacteriocidal. Bacterial resistance to one sulfonamide indicates resistance to all of them.

(CC) Image: David E. Volk
A sulfonamide

Glycopeptides

Oxazolidinones

Other Antibiotic

Adverse effects

Antibiotic resistance

For more information, see: antibiotic resistance.

A number of organisms have developed resistance to antibiotics. At the microbial level, this may be due either to the antibiotic therapy allowing the survival of naturally resistant organisms of the species, or of the transfer of resistance genetic factors among bacteria.

Diarrhea

Antibiotic associated diarrhea sometimes includes pseudomembranous enterocolitis caused by Clostridium difficile. Antibiotic associated diarrhea may be prevented by administering probiotics such as Lactobacillus.[1]

References

Primary references

The most up-to-date information about Antibiotic and other drugs can be found at the following sites.